Skye Bioscience, Inc. Common Stock (SKYE) — Strategic Asset Allocation Index
Skye Bioscience, Inc. Common Stock (SKYE) has a Strategic Asset Allocation Index of 18.3% as of September 2023. Strategic assets (PP&E of $309.83K plus long-term investments of $-) total $309.83K, measured against net assets of $1.70 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check SKYE financial resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Skye Bioscience, Inc. Common Stock Strategic Asset Allocation Index (2019–2021)
This chart shows how Skye Bioscience, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2021. As of September 2023, the index stands at 18.3%, representing strategic assets of $309.83K against net assets of $1.70 Million USD. See Skye Bioscience, Inc. Common Stock leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Skye Bioscience, Inc. Common Stock (2019–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Skye Bioscience, Inc. Common Stock from 2019 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Skye Bioscience, Inc. Common Stock worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 4.0% | $234.68K | $234.68K | $- | $5.86 Million | ▲ +2.4 pp |
| 2020 | 1.6% | $7.34K | $7.34K | $- | $450.79K | ▲ +1.3 pp |
| 2019 | 0.4% | $1.98K | $1.98K | $- | $548.06K | — |